Service de Chirurgie Hépatobiliaire et Digestive, Centre Hospitalier Universitaire de Rennes, Université de Rennes 1, Rennes Cedex, France,
Updates Surg. 2014 Jun;66(2):93-100. doi: 10.1007/s13304-013-0235-y. Epub 2013 Oct 2.
Cholangiocarcinoma is a malignant neoplasm that originates from biliary epithelial cells. Complete tumor resection remains the most effective treatment of intra-hepatic or perihilar cholangiocarcinomas (PHCs). The objectives of this are to update and discuss methods that are likely to increase the resectability of cholangiocarcinomas, and to define the limits beyond which the risks of the treatments outweigh their benefits. We analyzed intra-hepatic cholangiocarcinomas and PHCs separately to determine the site of origin and the resectability of the tumor. We discussed the site at which to perform hepatic optimization prior to surgery, and whether liver transplantation might affect cholangiocarcinoma treatment.
胆管癌是一种源自胆管上皮细胞的恶性肿瘤。完整的肿瘤切除术仍然是治疗肝内或肝门周围胆管癌（PHC）的最有效方法。其目的是更新和讨论可能增加胆管癌可切除性的方法，并确定治疗风险超过其益处的界限。我们分别分析了肝内胆管癌和 PHC，以确定肿瘤的起源部位和可切除性。我们讨论了在手术前进行肝脏优化的部位，以及肝移植是否会影响胆管癌的治疗。
